Evidence map›Paper›PMID 36729644›Full record

ArticleJCI insight2023

Defective jagged-1 signaling affects GnRH development and contributes to congenital hypogonadotropic hypogonadism.

Ludovica Cotellessa, Federica Marelli, Paolo Duminuco, Michela Adamo, Georgios E Papadakis, Lucia Bartoloni, Naoko Sato, Mariarosaria Lang-Muritano, Amineh Troendle, Waljit S Dhillo and 7 more

Abstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Association Study BetweenInternational journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ludovica CotellessaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Federica MarelliDepartment of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Paolo DuminucoDepartment of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Michela AdamoDepartment of Endocrinology, Diabetology, and Metabolism, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Georgios E PapadakisDepartment of Endocrinology, Diabetology, and Metabolism, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Lucia BartoloniDepartment of Endocrinology, Diabetology, and Metabolism, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Naoko SatoDepartment of Pediatrics, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Mariarosaria Lang-MuritanoDepartment of Pediatric Endocrinology and Diabetology, University Children's Hospital, Zurich, Switzerland.
Amineh TroendleDepartment of Endocrinology, Diabetology, and Metabolism, Lindenhofspital, Bern, Switzerland.
Waljit S DhilloDivision of Diabetes, Endocrinology and Metabolism, Imperial College London, London, United Kingdom.
Annamaria MorelliDepartment of Experimental and Clinical Medicine, University of Florence, Italy.
Giulia GuarnieriDepartment of Experimental and Clinical Medicine, University of Florence, Italy.
Nelly PitteloudDepartment of Endocrinology, Diabetology, and Metabolism, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Luca PersaniDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Marco BonomiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Paolo GiacobiniUniversity Lille, INSERM, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition UMR-S 1172, FHU 1000 days for health, Lille, France.
Valeria VezzoliDepartment of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vertebrate species, fertility is controlled by gonadotropin-releasing hormone (GnRH) neurons. GnRH cells arise outside the central nervous system, in the developing olfactory pit, and migrate along olfactory/vomeronasal/terminal nerve axons into the forebrain during embryonic development. Congenital hypogonadotropic hypogonadism (CHH) and Kallmann syndrome are rare genetic disorders characterized by infertility, and they are associated with defects in GnRH neuron migration and/or altered GnRH secretion and signaling. Here, we documented the expression of the jagged-1/Notch signaling pathway in GnRH neurons and along the GnRH neuron migratory route both in zebrafish embryos and in human fetuses. Genetic knockdown of the zebrafish ortholog of JAG1 (jag1b) resulted in altered GnRH migration and olfactory axonal projections to the olfactory bulbs. Next-generation sequencing was performed in 467 CHH unrelated probands, leading to the identification of heterozygous rare variants in JAG1. Functional in vitro validation of JAG1 mutants revealed that 7 out of the 9 studied variants exhibited reduced protein levels and altered subcellular localization. Together our data provide compelling evidence that Jag1/Notch signaling plays a prominent role in the development of GnRH neurons, and we propose that JAG1 insufficiency may contribute to the pathogenesis of CHH in humans.

Indexed as

Gonadotropin-Releasing HormoneHypogonadismAnimalsFemaleHumansJagged-1 ProteinPregnancySignal TransductionZebrafishGonadotropin-Releasing HormoneJagged-1 ProteinDevelopmentFertilityGenetic diseasesGeneticsNeurodevelopment

Identifiers

PMID36729644
PMCPMC10077483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.